Plovanic William J. Insider Trades

Insider Trading History

Track insider trading activity for Plovanic William J.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
TELA Bio
TELA Bio TELA
Director
Holding Value $15.5k 17,550 shares
Last Trade
Oct 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.3k 29,475 shares
$1.23
$0.88
Obalon Therapeutics
Obalon Therapeutics OBLN
Director, President & CFO
Holding Value $128k 41,806 shares
Last Trade
Aug 06, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$71.1k 21,875 shares
$3.25
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Director, President & CFO
Holding Value $915k 300,000 shares
Last Trade
Jul 23, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 300,000 shares
$9.60
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Director
Holding Value $894k 293,044 shares
Last Trade
Aug 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$731k 27,472 shares
$26.60
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Director
Holding Value $137k 45,000 shares
Last Trade
May 15, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 45,000 shares
$28.30
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Director
Holding Value $45.8k 15,000 shares
Last Trade
Mar 14, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$212k 5,300 shares
$40.00
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Director
Holding Value $29.2k 9,588 shares
Last Trade
Mar 13, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$783k 19,288 shares
$40.60
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Chief Financial Officer
Holding Value $168k 55,000 shares
Last Trade
Nov 09, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.81M 55,000 shares
$87.40
$3.05

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up